Fondaparinux overdose: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
Zorkun (talk | contribs)
Bureaucrats, interwiki, Administrators
86,579 edits
No edit summary
Alejandro Lemor (talk | contribs)
nocaptcha, Administrators
7,091 edits
←Redirected page to Fondaparinux#Overdosage
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
{{CMG}}
#REDIRECT [[Fondaparinux#Overdosage]]


==Overdose==
[[Category: Cardiovascular Drugs]]
 
[[Category: Drug]]
There is no known antidote for Arixtra Injection. Overdose of Arixtra may lead to hemorrhagic complications. Overdosage associated with bleeding complications should lead to treatment discontinuation and initiation of appropriate therapy.
[[Category: Anticoagulants]]
 
Data obtained in patients undergoing chronic intermittent hemodialysis suggest that clearance of Arixtra can increase by 20% during hemodialysis.
 
 
 
 
{{FDA}}
 
 
 
 
 
 
[[Category:Drugs]]

Latest revision as of 16:22, 21 July 2014

Redirect to:

Retrieved from "https://www.wikidoc.org/index.php?title=Fondaparinux_overdose&oldid=996869"